---
type: "Symbol"
title: "DAJIAWEIKANG (301126.SZ) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/301126.SZ/topics.md"
symbol: "301126.SZ"
parent: "https://longbridge.com/en/quote/301126.SZ.md"
count: 1
datetime: "2026-03-08T11:35:12.105Z"
locales:
  - [en](https://longbridge.com/en/quote/301126.SZ/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301126.SZ/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301126.SZ/topics.md)
---

# DAJIAWEIKANG (301126.SZ) — Community Discussions

### [达嘉维康精耕湖南，大健康产业链蓄势待发](https://longbridge.com/en/topics/2421908.md)

- Author: [斑马消费](https://longbridge.com/en/profiles/6226040.md)
- Datetime: 2022-04-26T00:19:39.000Z
- Comments: 0
- 区域性医药流通企业，如何做大做强？达嘉维康给出了一份参考答案。公司深耕湖南市场，以医院分销为业绩基石，聚焦专业药房发展，以连锁药店为拓展增量，通过 “互联网 + 药品流通” 模式扩宽赛道，建成了具有自身特色的大健康产业链。2021 年末，公司登陆资本市场，交出了营收、业绩双增长的首份成绩单。 业绩双增长上市首年，创新型医药企业达嘉维康（301126.SZ），给市场交出了一份不错的成绩单。25 日.

## References

- [DAJIAWEIKANG (301126.SZ)](https://longbridge.com/en/quote/301126.SZ.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301126.SZ/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301126.SZ/topics.md)